Because some participants were confused about “aromatase inhibitor therapy” (they thought that their adjuvant medication was hormone treatment and that AI therapy referred to something new), the title was changed to Walk With Ease for Women with a Breast Cancer Diagnosis (WWE-BC). Here, CYP19A1 is linked to breast cancer.